Background Inflammatory bowel disease is a global disease in the 21st century. We aimed
to assess the changing incidence and prevalence of inflammatory bowel disease around the …

Background & Aims The epidemiology of Helicobacter pylori infection has changed with
improvements in sanitation and methods of eradication. We performed a systematic review and …

BACKGROUND & AIMS: Inflammatory bowel diseases (IBD) are becoming more common in
Asia, but epidemiologic data are lacking. The Asia-Pacific Crohn’s and Colitis Epidemiology …

Background After endoscopic treatment of bleeding peptic ulcers, bleeding recurs in 15 to
20 percent of patients. Methods We assessed whether the use of a high dose of a proton-…

Background Concurrent therapy with a proton-pump inhibitor is a standard treatment for
patients receiving aspirin who are at risk for ulcer. Current US guidelines also recommend …

Background Many patients who have had upper gastrointestinal bleeding continue to take
low-dose aspirin for cardiovascular prophylaxis or other nonsteroidal antiinflammatory drugs (…

Background Current guidelines recommend that patients at risk for ulcer disease who
require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are …

Background: It is uncertain whether aspirin therapy should be continued after endoscopic
hemostatic therapy in patients who develop peptic ulcer bleeding while receiving low-dose …

Objective A global consensus meeting was held to review current evidence and knowledge
gaps and propose collaborative studies on population-wide screening and eradication of …

Background Guidelines on pain management recommend that patients at risk of ulcers
receive either a cyclo-oxygenase (COX 2) inhibitor or a non-steroidal anti-inflammatory drug (…